Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Cartwright

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Circulation|November 16, 2011
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heartWei Liu, Min Zi, Ronald Naumann, et al.
Journal of the American Heart Association|June 15, 2023
Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin IIBinh Y Nguyen, Fangchao Zhou, Pablo Binder, et al.
Circulation Research|February 3, 2007
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractilityNatalie Burkard, Adam G Rokita, Susann G Kaufmann, et al.
Nature Communications|September 10, 2017
Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signalingWei Liu, Andrea Ruiz-Velasco, Shoubao Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 28, 2011
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injuryEmmanuel Eroume A Egom, Tamer M A Mohamed, Mamas A Mamas, et al.
Elife|April 1, 2020
Targeting <i>mir128-3p</i> alleviates myocardial insulin resistance and prevents ischemia-induced heart failureAndrea Ruiz-Velasco, Min Zi, Susanne S Hille, et al.
The Journal of Biological Chemistry|April 2, 2011
Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesisMin Zi, Tomomi E Kimura, Wei Liu, et al.
Journal of the American Heart Association|April 12, 2014
Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with ageLaura Davies, Jiawei Jin, Weijin Shen, et al.
Circulation. Heart Failure|June 12, 2013
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostinWei Liu, Min Zi, Hoyee Tsui, et al.
The Journal of Biological Chemistry|October 4, 2011
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomainTamer M A Mohamed, Delvac Oceandy, Min Zi, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Circulation|November 16, 2011
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heartWei Liu, Min Zi, Ronald Naumann, et al.
Journal of the American Heart Association|June 15, 2023
Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin IIBinh Y Nguyen, Fangchao Zhou, Pablo Binder, et al.
Circulation Research|February 3, 2007
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractilityNatalie Burkard, Adam G Rokita, Susann G Kaufmann, et al.
Nature Communications|September 10, 2017
Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signalingWei Liu, Andrea Ruiz-Velasco, Shoubao Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 28, 2011
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injuryEmmanuel Eroume A Egom, Tamer M A Mohamed, Mamas A Mamas, et al.
Elife|April 1, 2020
Targeting <i>mir128-3p</i> alleviates myocardial insulin resistance and prevents ischemia-induced heart failureAndrea Ruiz-Velasco, Min Zi, Susanne S Hille, et al.
The Journal of Biological Chemistry|April 2, 2011
Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesisMin Zi, Tomomi E Kimura, Wei Liu, et al.
Journal of the American Heart Association|April 12, 2014
Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with ageLaura Davies, Jiawei Jin, Weijin Shen, et al.
Circulation. Heart Failure|June 12, 2013
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostinWei Liu, Min Zi, Hoyee Tsui, et al.
The Journal of Biological Chemistry|October 4, 2011
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomainTamer M A Mohamed, Delvac Oceandy, Min Zi, et al.
Pageof 9